Inhalation Warnings For Aerosolized Antip/Deo Is Not Redundant – FDA
This article was originally published in The Rose Sheet
Executive Summary
The need for two inhalation warnings on labeling for aerosolized dosage forms in the OTC Antiperspirant Drug Products Final Monograph is justified, FDA says in a Feb. 17 letter to the Cosmetic, Toiletry and Fragrance Association, partially denying a citizen petition submitted by the trade group